ITEM 8.01 Other Events.

By letter dated January 21, 2020, Nasdaq confirmed to Second Sight Medical Products Inc. (the "Company") that for the last 10 consecutive business days, from January 6 to January 17, 2020, the closing bid price of the Company's common stock has been at $1.00 per share or greater. Nasdaq had previously informed the Company in January 2019 that the common stock of the Company failed to maintain a bid price of $1.00 over the previous 30 consecutive business days as required by the Listing Rules of the Nasdaq Stock Market. Accordingly, the Company has regained compliance with Listing Rule 5550(a)(2) and this matter is now closed.

© Edgar Online, source Glimpses